Company intelligence / Profile preview

Amaran Biotech

Zhubei City, Hsinchu, Taiwan

Ownership: Private
Development stage: Other

Overview

Amaran Biotech is a leading Taiwanese CDMO providing PIC/S GMP-certified manufacturing services for biologics, gene therapy, antibodies, vaccines, and novel complex drugs, with strengths in process development, aseptic robotic fill-finish, and commercial-scale adjuvant (QS-21/AB-801) production. Commercial programs developed here have achieved successful NDA approvals in the US, Europe, and Canada for clients[6][7][9][14].

Therapeutic areas: OncologyImmunologyInfectious Diseases
Modalities: BiologicGlycoproteinAdjuvantProteinLipid nanoparticle delivery therapyMonoclonal antibodyGene therapy
Industry: Contract Manufacturing Organization

Partnerships

Nippon Fine ChemicalZillion Fine Chemicals InternationalStellar Biotechnologies (historical)Various global biotech/pharma clients using CDMO services

Beyond the preview

Go deeper on Amaran Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Amaran Biotech.

Explore the full profile